Biofourmis, a Singapore-headquartered digital HealthTech company founded in 2015, announced today it has raised US$5.0 million in a Series A round of funding from NSI Ventures and Aviva Ventures, the strategic corporate venture arm of the international insurer, Aviva plc. Biofourmis has also entered into a collaboration with Mayo Clinic, which would enable the company […]
The post Biofourmis raises US$5 Million in Series A financing from Nsi Ventures and Aviva Ventures appeared first on Biotechin.Asia.
This post first appeared on Biotechin.asia – Your Daily Biotech And Healthca, please read the originial post: here
